Veterinary genomics is rapidly expanding from breed identification to disease prediction, pharmacogenomics, and personalized therapeutic selection. Embark Veterinary, Wisdom Panel (Mars), and Basepaws (Zoetis) lead the consumer DNA testing market, generating $300M+ in 2025. Clinical applications including pharmacogenomic testing for chemotherapy dose optimization and breed-specific drug sensitivity testing are gaining adoption. The MDR1 gene mutation test for collies and herding breeds is now standard pre-prescription practice for ivermectin, loperamide, and other affected drugs.
This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
Topics Covered
• Veterinary Genomics Market Size, Growth and Forecast 2025-2030
• Consumer DNA Testing — Embark, Wisdom Panel, Basepaws
• Breed Identification and Lineage Testing
• Disease Prediction and Genetic Risk Profiling
• Pharmacogenomics — Drug Sensitivity and Dose Optimization
• MDR1 Gene Testing and Drug Selection
• Cancer Genomics — IDEXX Cancer Dx, PetDx Liquid Biopsy
• Inherited Disease Testing in Pure Breeds
• Whole Genome Sequencing Adoption in Veterinary Medicine
• Personalized Therapeutic Selection Based on Genetic Profile
Table of Contents
1. Executive Summary
2. Market Overview
3. Veterinary Genomics Market Size, Growth and Forecast 2025-2030
4. Consumer DNA Testing
5. Breed Identification
6. Disease Prediction
7. Pharmacogenomics
8. MDR1 Gene Testing
9. Cancer Genomics
10. Inherited Disease Testing
11. Whole Genome Sequencing
12. Personalized Therapeutic Selection
13. Market Challenges and Risks
14. Competitive Landscape
15. Strategic Conclusions and Recommendations
16. Appendix
List of Tables
Table 1. Veterinary Genomics Market Size and Forecast 2025-2030
Table 2. Consumer DNA Test Sales — Embark, Wisdom Panel, Basepaws
Table 3. Disease Prediction Test Volume by Indication
Table 4. Pharmacogenomic Test Adoption by Breed
Table 5. MDR1 Gene Test Volume and Drug Selection Impact
Table 6. Cancer Genomics Test Sales — IDEXX, PetDx
Table 7. Inherited Disease Test Catalog by Breed
Table 8. Whole Genome Sequencing Cost Trends 2018-2030
Table 9. Personalized Therapeutic Selection Pilot Programs
Table 10. Competitive Positioning by Genomics Application
Companies Profiled
Basepaws
Embark Veterinary
IDEXX Laboratories
PetDx
Wisdom Panel
Zoetis
